2.94
-1.01%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Tong Ren Tang Technologies Co
Its shares trade on HKEX under the ticker 1666.HK. It has been listed since 31 October 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.56bn and net income of CN¥462.2m. At that date it held total assets of CN¥16.00bn and shareholders' equity of CN¥8.57bn.
Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. The company is headquartered in Beijing, Beijing. The company went IPO on 2000-10-31. The firm's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The firm is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The firm mainly distributes its products in the domestic market and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 31 Oct 2000
- Employees
- 4,030
- Website
- tongrentangkj.com ↗
Leadership
Pay as last reported
- Mr. Shu Bing DiExecutive Chairman of the Board, since 2024
- Mr. Guan Zhao HanDeputy General Manager, General Legal Counsel
- Mr. Jia Fu ChenGeneral Manager, Executive DirectorCN¥605,000
- Mr. Ling Yun DongDeputy General Manager
- Mr. Jun Wei GuanDeputy General Manager
- Mr. Feng ZhangDeputy General Manager
- Mr. Shu Wu ZhaoDeputy General Manager
- Ms. Zhi Mei FengExecutive Director, since 2021CN¥998,000
- Mr. Yijun LiCompany Secretary
- Ms. Li FengNon-Executive Director
- Ms. Chun Rui WangNon-Executive Director
- Mr. Yi ZhangNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 70
- Environment
- 79
- Social
- 65
- Governance
- 67
- Direct emissions (scope 1)
- 30,000 t
- Energy emissions (scope 2)
- 60,000 t
- Women in the workforce
- 53.47476%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Tong Ren Tang Technologies employs 4,030 full-time employees in Beijing.
- The company produces and distributes traditional Chinese medicine products domestically and overseas.
- Tong Ren Tang Technologies has been listed since 31 October 2000.
Weaknesses
- The company's main business focuses on traditional Chinese medicine without diversification.
- Tong Ren Tang Technologies operates primarily in the domestic market with limited international presence.
- The firm's reliance on Chinese herbal medicine production may limit growth opportunities.
Opportunities
- Expanding into overseas markets for traditional Chinese medicine products.
- Growing demand for health care products in the domestic market.
- Increasing interest in traditional Chinese medicine globally.
Threats
- Competition from other pharmaceutical companies in the Health Care sector.
- Regulatory changes affecting traditional Chinese medicine production.
- Economic downturns impacting consumer spending on health care products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.